News Focus
News Focus
icon url

Roman516

12/14/25 2:48 PM

#802882 RE: HyGro #802873

Facts prove NWBO OS data surpassed the P3 data!

NoGrow, per your comments.

"Facts are Facts - NWBO clearly did not get the green light from FDA to file based on the P3 data. The heavily manipulated trial violated multiple FDA guidelines regardless of how you spin it. That's why NWBO went to the UK. NWBO filed all of their trials with the FDA and showed every intent on wanting to file with the FDA as any biotech would want to. But yet.....years later still NO APPLICATION AT THE FDA!!!!"
Still never received your official feedback as you mentioned that you had proof that the FDA rejected NWBO.

You know that NWBO should be approved and that is a fact. Furthermore, sad how many drugs in the USA are approved and most of them have extremely negative side effects.
However, NWBO, DCVax-L appears to have no side effects and has the ability to help extend and cure both nGBM and rGBM cancer and NWBOs DCVax-D could be well on its way to address 80% solid tumors. The FDA is fully aware of the supporting facts for NWBO, it is just a matter of time for approval for NWBO, IMPO.
Bullish
Bullish